2019
DOI: 10.1002/jmv.25456
|View full text |Cite
|
Sign up to set email alerts
|

Genetic diversity of influenza A(H3N2) viruses in Northern Cameroon during the 2014‐2016 influenza seasons

Abstract: In Cameroon, genome characterization of influenza virus has been performed only in the Southern regions meanwhile genetic diversity of this virus varies with respect to locality. The Northern region characterized by a Sudan tropical climate might have distinct genetic characterization. This study aimed to better understand the genetic diversity of influenza A(H3N2) viruses circulating in Northern Cameroon. Sequences of three gene segments (hemagglutinin (HA), neuraminidase (NA) and matrix (M) genes) were obtai… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
19
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 6 publications
(20 citation statements)
references
References 27 publications
(37 reference statements)
1
19
0
Order By: Relevance
“…In 2014, new strains similar to the 2014 SH season A/Texas/50/2012(H3N2) vaccine strain were sampled in Congo [ 97 ], South Africa [ 77 ], and Southern and Northern Cameroon [ 78 , 79 ]. The A/Texas/50/2012(H3N2) vaccine showed low efficacy in South Africa (VE: −18.4% (−171.5 to −48.4) [ 77 ], and the majority of the sampled Congo and South Cameroon strains were also antigenically similar to the A/Switzerland/9715293/2013(H3N2) vaccine strain used later in 2015 [ 78 , 97 ].…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…In 2014, new strains similar to the 2014 SH season A/Texas/50/2012(H3N2) vaccine strain were sampled in Congo [ 97 ], South Africa [ 77 ], and Southern and Northern Cameroon [ 78 , 79 ]. The A/Texas/50/2012(H3N2) vaccine showed low efficacy in South Africa (VE: −18.4% (−171.5 to −48.4) [ 77 ], and the majority of the sampled Congo and South Cameroon strains were also antigenically similar to the A/Switzerland/9715293/2013(H3N2) vaccine strain used later in 2015 [ 78 , 97 ].…”
Section: Resultsmentioning
confidence: 99%
“…H3N2 strains sampled in Egypt strains between 2015 and 2017 had several mutated antigenic sites A (T135K, R142G/K/A, N144K/S, N145S), B (L157S, F159Y, K160T), C (D53N/G, N278K), and D (N121D/K/S, N225D), and all had the non-agglutinating substitution N225D [ 101 ]. Strains sampled in the same period (2015–2017) from Northern and Southern Cameroon were similar to the 2016–2017 season SNH A/Hong Kong/4801/2014(H3N2) vaccine strain but had different dominant antigenic sites resulting in different efficacy of the A/Switzerland/9715293/2013(H3N2) vaccine in Northern (80.55%) and Southern Cameroon (17%) in 2015 [ 78 , 79 ].…”
Section: Resultsmentioning
confidence: 99%
“…Due to similar clinical presentations to other infectious agents, presumptive treatment of influenza in hospital settings usually involves the administration of antimalarial and antibacterial drugs which could have as consequence the development of anti-microbial resistance [13]. Meanwhile, previous genomic data has shown that neuraminidase inhibitors are potent antivirals that could be used for influenza therapy in Cameroon [14][15][16][17]. Thus, predicting influenza can have important healthcare benefits to the individual as well as to the community.…”
Section: Introductionmentioning
confidence: 99%
“…In this paper we aim to model and nowcast (hereafter referred to as, forecast) ILI in Cameroon using data from a surveillance system for influenza and ILI implemented by the Ministry of Health (MOH) in Cameroon 28 . Recent studies on influenza and ILI surveillance in Cameroon have focused on viral identification 29 , understanding genetic diversity 30,31 , and seasonality of All rights reserved. No reuse allowed without permission.…”
Section: Introductionmentioning
confidence: 99%